Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News HTG Molecular Diagnostics Inc HTGMQ

HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and... see more

Recent & Breaking News (GREY:HTGMQ)

HTG Introduces HTG EdgeSeq Reveal RUO Oncology Applications

GlobeNewswire August 4, 2020

HTG Expands RUO Profiling Menu with New NGS Platform Capability Assays

GlobeNewswire July 30, 2020

HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel

GlobeNewswire July 28, 2020

HTG Announces Recipients of Its 2020 HTG EdgeSeq Autoimmune Panel Research Grants

GlobeNewswire July 23, 2020

HTG Molecular Diagnostics Secures Senior Term Loan from Silicon Valley Bank

GlobeNewswire June 25, 2020

HTG EdgeSeq Technology Highlighted in Multiple Posters Presented by Pharma Partners at the 2020 American Association for Cancer Research Virtual Meeting

GlobeNewswire June 23, 2020

HTG Introduces the HTG EdgeSeq Pan B-Cell Lymphoma Panel

GlobeNewswire June 18, 2020

HTG Adds Three New Distributors in Europe, Expanding and Strengthening Reach in the Nordics and Eastern Europe

GlobeNewswire June 11, 2020

HTG EdgeSeq Technology Highlighted in Several Posters at ASCO

GlobeNewswire June 2, 2020

HTG Molecular Diagnostics Reports First Quarter 2020 Results

GlobeNewswire May 13, 2020

HTG Molecular Diagnostics to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 13

GlobeNewswire May 11, 2020

HTG Molecular Diagnostics Reports Full Year 2019 Results

GlobeNewswire March 25, 2020

HTG Molecular Diagnostics to Announce Year End 2019 Financial Results and Host Conference Call on Wednesday, March 25

GlobeNewswire March 17, 2020

HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference

GlobeNewswire February 19, 2020

HTG EdgeSeq Mouse mRNA Tumor Response Panel Used by Researchers Targeting Cardiac Fibrosis with Engineered T-cells

GlobeNewswire February 11, 2020

HTG EdgeSeq miRNA Whole Transcriptome Assay is Highly Reproducible in Biofluids for Potential Use as a Biomarker

GlobeNewswire February 5, 2020

HTG Molecular Diagnostics Receives European Patent Grant Notification for Methods for Subtyping Diffuse Large B-cell Lymphoma

GlobeNewswire January 28, 2020

HTG Molecular Diagnostics Announces Preliminary 2019 Unaudited Financial Results

GlobeNewswire January 13, 2020

HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on the Future of Precision Medicine

GlobeNewswire December 3, 2019

HTG Molecular Diagnostics Expands Analytics Capabilities with Release of New Software Update

GlobeNewswire November 19, 2019